0001192482-19-000502.txt : 20191209 0001192482-19-000502.hdr.sgml : 20191209 20191209184228 ACCESSION NUMBER: 0001192482-19-000502 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191205 FILED AS OF DATE: 20191209 DATE AS OF CHANGE: 20191209 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Berelowitz Michael CENTRAL INDEX KEY: 0001493383 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36329 FILM NUMBER: 191276279 MAIL ADDRESS: STREET 1: 415 EAST 37TH STREET STREET 2: APT 36C CITY: NEW YORK STATE: NY ZIP: 10016 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Recro Pharma, Inc. CENTRAL INDEX KEY: 0001588972 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 261523233 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 490 LAPP ROAD CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: (484) 395-2400 MAIL ADDRESS: STREET 1: 490 LAPP ROAD CITY: MALVERN STATE: PA ZIP: 19355 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2019-12-05 0001588972 Recro Pharma, Inc. REPH 0001493383 Berelowitz Michael C/O RECRO PHARMA, INC. 490 LAPP ROAD MALVERN, PA 19355 1 0 0 0 Common Stock 2019-12-05 4 A 0 13848 0 A 41260 D These restricted stock units will vest in full on the earlier of (i) a change of control of Recro Pharma, Inc. (the "Company") (as defined in the Company's 2018 Amended and Restated Equity Incentive Plan) or (ii) December 5, 2020, subject to continued service with the Company. /s/ Ryan D. Lake, Attorney-in-fact 2019-12-09